The lactate-related risk score, constructed using ADAMTS3, FADS2, and RTBDN, was further explored to assess their expression and prognostic value for radiotherapy patients with lung cancer across multiple databases. This evidence concerns the gene ADAMTS3 and lung carcinoma.